Research Article


DOI :10.26650/IUITFD.2020.0090   IUP :10.26650/IUITFD.2020.0090    Full Text (PDF)

THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES

Yasin Kutluİlkim Deniz ToprakYasemin GökdenHasan EruzunYücel ArmanŞengül Aydın YoldemirZeki ToprakTufan Tükek

Objective: In inflammatory bowel disease (IBD), there is no reliable biomarker, yet. We aimed to determine whether Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) could be useful as a marker for the diagnosis and/or the determination of disease activity in patients with IBD. Material and Method: A total of 47 patients with ulcerative colitis (UC) and 25 patients with Crohn’s disease (CD) were prospectively enrolled. Clinical disease activity was analyzed using the Crohn’s Disease Activity Index (CDAI) for CD and the Truelove-Witts index for UC. Results: sTREM-1 levels were significantly lower in patients with IBD compared to healthy controls (p=0.001). In comparison of the levels of sTREM-1 between the different groups (CD, UC, and healthy controls) the difference was statistically significant. No considerable differences in sTREM-1 levels were determined in patients with active versus quiescent disease. The sTREM-1 levels negatively correlated with C-reactive protein, blood neutrophil-lymphocyte ratio, and positively with haemoglobin levels. Conclusion: sTREM-1 levels are decreased in IBD patients compared with the healthy individuals. It may, therefore, be useful for the diagnosis of IBD. However, it does not seem to be a precise marker of disease activity in IBD and cannot be suggested for assessing disease activity in these patients.

DOI :10.26650/IUITFD.2020.0090   IUP :10.26650/IUITFD.2020.0090    Full Text (PDF)

İNFLAMATUAR BARSAK HASTALIKLARI AKTİVASYONU İLE sTREM-1 ARASINDAKİ İLİŞKİ

Yasin Kutluİlkim Deniz ToprakYasemin GökdenHasan EruzunYücel ArmanŞengül Aydın YoldemirZeki ToprakTufan Tükek

Amaç: İnflamatuar barsak hastalıkları (İBS) tanısında henüz uygun bir biyobelirteç bulunmamıştır. Çalışmamızda STREM-1 molekülünün bir belirteç olarak, İBS tanısında ve hastalık aktivitesini belirlemede uygunluğunu belirlemeyi amaçladık. Gereç ve Yöntem: Toplam 47 ülseratif kolit ve 25 Crohn hastalığı tanılı vaka çalışmaya dahil edildi. Crohn hastalığı için aktiviteyi belirlemede Crohn Hastalığı Aktivite İndeksi (CDAI), ülseratif kolit için ise Truelove-Witts indeksi kullanıldı. Bulgular: Sağlıklı grupla kıyaslandığında, sTREM-1 molekülü, İBS hastalarında anlamlı derecede düşük saptandı. Ülseratif kolit, Crohn hastalığı ve sağlıklı grup arasında sTREM-1 molekülü kıyaslandığında ise fark istatiksel olarak anlamlıydı. Aktif ve remisyonda olan hastalarda sTREM-1 düzeylerinde önemli bir fark bulunmamıştır. sTREM-1 seviyeleri C-reaktif protein, nötrofil-lenfosit oranı ve hemoglobin düzeyleri ile negatif korelasyon gösterdi. Sonuç: sTREM-1 seviyeleri İBS’de sağlıklı bireylere göre daha düşüktür. İBS tanısı için yararlı olabilir. Ancak, İBS’de hastalık aktivitesinin belirlemede doğru bir belirteç gibi görünmemektedir ve bu hastalarda hastalığın aktivitesini değerlendirmek için önerilemez. 


PDF View

References

  • 1. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164(10):4991-5. [CrossRef] google scholar
  • 2. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006;55(3):426-31. [CrossRef] google scholar
  • 3. Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 2007;8(4):171-8. [CrossRef] google scholar
  • 4. Bassyouni IH, Fawzi S, Gheita TA, Bassyouni RH, Nasr AS, El Bakry SA, et al. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus. Immunol Invest 2017;46(1):38-47. [CrossRef] google scholar
  • 5. Liu M, Wu W, Zhao Q, Feng Q, Wang W. High Expression Levels of Trigger Receptor Expressed on Myeloid Cells-1 on Neutrophils Associated with Increased Severity of Acute Pancreatitis in Mice. Biol Pharm Bull 2015;38(10):1450-7. [CrossRef] google scholar
  • 6. Essa ES, Elzorkany KM. sTREM-1 in patients with chronic kidney disease on hemodialysis. APMIS 2015;123(11):969-74. [CrossRef] google scholar
  • 7. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976;70(3):439-44. [CrossRef] google scholar
  • 8. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2(4947):1041-8. [CrossRef] google scholar
  • 9. Desai D, Faubion WA, Sandborn WJ. Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007;25(3):247-55. [CrossRef] google scholar
  • 10. Tzivras M, Koussoulas V, Giamarellos-Bourboulis EJ, Tzivras D, Tsaganos T, Koutoukas P, et al. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J Gastroenterol 2006;12(21):3416-9. [CrossRef] google scholar
  • 11. Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, et al. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 2009;54(7):1525-31. [CrossRef] google scholar
  • 12. Billioud V, Gibot S, Massin F, Oussalah A, Chevaux JB, Williet N, et al. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn’s disease. Dig Liver Dis 2012;44(6):466-70. [CrossRef] google scholar
  • 13. Radsak MP, Taube C, Haselmayer P, Tenzer S, Salih HR, Wiewrodt R, et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007;2007:52040. [CrossRef] google scholar
  • 14. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, et al. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 2008;36(7):2048-53. [CrossRef] google scholar
  • 15. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410(6832):1103-7. [CrossRef] google scholar
  • 16. Schultsz C, Van Den Berg FM, Ten Kate FW, Tytgat GN, Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999;117(5):1089-97. [CrossRef] google scholar
  • 17. BrazilJC,LouisNA,ParkosCA.Theroleofpolymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis 2013;19(7):1556-65. [CrossRef] google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Kutlu, Y., Toprak, İ.D., Gökden, Y., Eruzun, H., Arman, Y., Aydın Yoldemir, Ş., Toprak, Z., & Tükek, T. (2021). THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES. Journal of Istanbul Faculty of Medicine, 84(3), 318-323. https://doi.org/10.26650/IUITFD.2020.0090


AMA

Kutlu Y, Toprak İ D, Gökden Y, Eruzun H, Arman Y, Aydın Yoldemir Ş, Toprak Z, Tükek T. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES. Journal of Istanbul Faculty of Medicine. 2021;84(3):318-323. https://doi.org/10.26650/IUITFD.2020.0090


ABNT

Kutlu, Y.; Toprak, İ.D.; Gökden, Y.; Eruzun, H.; Arman, Y.; Aydın Yoldemir, Ş.; Toprak, Z.; Tükek, T. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 3, p. 318-323, 2021.


Chicago: Author-Date Style

Kutlu, Yasin, and İlkim Deniz Toprak and Yasemin Gökden and Hasan Eruzun and Yücel Arman and Şengül Aydın Yoldemir and Zeki Toprak and Tufan Tükek. 2021. “THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES.” Journal of Istanbul Faculty of Medicine 84, no. 3: 318-323. https://doi.org/10.26650/IUITFD.2020.0090


Chicago: Humanities Style

Kutlu, Yasin, and İlkim Deniz Toprak and Yasemin Gökden and Hasan Eruzun and Yücel Arman and Şengül Aydın Yoldemir and Zeki Toprak and Tufan Tükek. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES.” Journal of Istanbul Faculty of Medicine 84, no. 3 (Nov. 2024): 318-323. https://doi.org/10.26650/IUITFD.2020.0090


Harvard: Australian Style

Kutlu, Y & Toprak, İD & Gökden, Y & Eruzun, H & Arman, Y & Aydın Yoldemir, Ş & Toprak, Z & Tükek, T 2021, 'THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES', Journal of Istanbul Faculty of Medicine, vol. 84, no. 3, pp. 318-323, viewed 23 Nov. 2024, https://doi.org/10.26650/IUITFD.2020.0090


Harvard: Author-Date Style

Kutlu, Y. and Toprak, İ.D. and Gökden, Y. and Eruzun, H. and Arman, Y. and Aydın Yoldemir, Ş. and Toprak, Z. and Tükek, T. (2021) ‘THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES’, Journal of Istanbul Faculty of Medicine, 84(3), pp. 318-323. https://doi.org/10.26650/IUITFD.2020.0090 (23 Nov. 2024).


MLA

Kutlu, Yasin, and İlkim Deniz Toprak and Yasemin Gökden and Hasan Eruzun and Yücel Arman and Şengül Aydın Yoldemir and Zeki Toprak and Tufan Tükek. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 3, 2021, pp. 318-323. [Database Container], https://doi.org/10.26650/IUITFD.2020.0090


Vancouver

Kutlu Y, Toprak İD, Gökden Y, Eruzun H, Arman Y, Aydın Yoldemir Ş, Toprak Z, Tükek T. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES. Journal of Istanbul Faculty of Medicine [Internet]. 23 Nov. 2024 [cited 23 Nov. 2024];84(3):318-323. Available from: https://doi.org/10.26650/IUITFD.2020.0090 doi: 10.26650/IUITFD.2020.0090


ISNAD

Kutlu, Yasin - Toprak, İlkimDeniz - Gökden, Yasemin - Eruzun, Hasan - Arman, Yücel - Aydın Yoldemir, Şengül - Toprak, Zeki - Tükek, Tufan. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES”. Journal of Istanbul Faculty of Medicine 84/3 (Nov. 2024): 318-323. https://doi.org/10.26650/IUITFD.2020.0090



TIMELINE


Submitted15.07.2020
Accepted01.11.2020
Published Online05.07.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.